AGEX THERAPEUTICS

agex-therapeutics-logo

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Ti... ssue Regeneration (iTR) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology.

#SimilarOrganizations #People #Financial #Website #More

AGEX THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2017-01-01

Address:
Alameda, California, United States

Country:
United States

Website Url:
http://www.agexinc.com

Total Employee:
101+

Status:
Active

Contact:
(510)871-4190

Email Addresses:
[email protected]

Total Funding:
99.79 M USD

Technology used in webpage:
SPF HSTS Nginx Microsoft Exchange Online Office 365 Mail Google Google Cloud Microsoft Azure DNS DNSSEC HSTS IncludeSubdomains PreLoad


Similar Organizations

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

not_available_image

Georgiamune

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

gritstone-bio-logo

Gritstone Bio

Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

michael-h-mulroy_image

Michael H. Mulroy Board Member @ AgeX Therapeutics
Board_member
2014-10-01

greg-bailey_image

Greg Bailey Board Chairman @ AgeX Therapeutics
Board_member

michael-d-west_image

Michael D West Board Member @ AgeX Therapeutics
Board_member

annalisa-jenkins_image

Annalisa Jenkins Board Member @ AgeX Therapeutics
Board_member

john-mauldin_image

John Mauldin Board Member @ AgeX Therapeutics
Board_member

Current Employees Featured

michael-d-west_image

Michael D West
Michael D West CEO @ AgeX Therapeutics
CEO
2016-01-01

ivan-labat_image

Ivan Labat
Ivan Labat CIO @ AgeX Therapeutics
CIO

hal-sternberg_image

Hal Sternberg
Hal Sternberg VP of Reasearch @ AgeX Therapeutics
VP of Reasearch

not_available_image

Judith Segall
Judith Segall Corporate Secretary @ AgeX Therapeutics
Corporate Secretary
2017-01-01

Founder


michael-d-west_image

Michael D West

Stock Details


Company's stock symbol is NYSE:AGE

Investors List

juvenescence_image

Juvenescence

Juvenescence investment in Private Equity Round - AgeX Therapeutics

juvenescence_image

Juvenescence

Juvenescence investment in Private Equity Round - AgeX Therapeutics

kizoo_image

KIZOO Technology Capital

KIZOO Technology Capital investment in Venture Round - AgeX Therapeutics

jim-mellon_image

Jim Mellon

Jim Mellon investment in Venture Round - AgeX Therapeutics

john-mauldin_image

John Mauldin

John Mauldin investment in Venture Round - AgeX Therapeutics

ibs-capital_image

IBS Capital

IBS Capital investment in Venture Round - AgeX Therapeutics

lineage-cell-therapeutics_image

Lineage Cell Therapeutics

Lineage Cell Therapeutics investment in Venture Round - AgeX Therapeutics

alfred-kingsley_image

Alfred Kingsley

Alfred Kingsley investment in Venture Round - AgeX Therapeutics

Official Site Inspections

http://www.agexinc.com Semrush global rank: 5.09 M Semrush visits lastest month: 1.57 K

  • Host name: 12.60.154.104.bc.googleusercontent.com
  • IP address: 104.154.60.12
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "AgeX Therapeutics"

AgeX Therapeutics, Inc. - Investor Relations

Mar 26, 2024 AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. We are building upon the foundation of our proprietary …See details»

AgeX Therapeutics - Crunchbase Company Profile

Organization. AgeX Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»

AgeX Therapeutics - Wikipedia

AgeX Therapeutics, Inc. (commonly abbreviated as AgeX Therapeutics or simply AgeX) is an American biotechnology company developing medical therapeutics related to human longevity. It was founded in 2017 by Michael D. West, initially as a subsidiary of BioTime, Inc. with backing from British billionaire investor Jim Mellon and others. The chairman is Gregory Bailey, who was an early backer and board member of Medivation until i…See details»

AgeX Therapeutics - Overview, News & Similar companies

Aug 29, 2023 AgeX Therapeutics contact info: Phone number: (510) 671-8370 Website: www.agexinc.com What does AgeX Therapeutics do? AgeX Therapeutics, Inc. (NYSE …See details»

AgeX Therapeutics, Inc. | LinkedIn

AgeX Therapeutics, Inc. Biotechnology Alameda, California 3,784 followers AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging.See details»

AgeX Therapeutics, Inc. Overview | SignalHire Company Profile

Organization Website. agexinc.com . Phone Number (510)671-8370. AgeX Therapeutics, I... industries. Biotech Headquarters Location. 1101 Marina Village Pkwy, Alameda, California, …See details»

AgeX Therapeutics Company Profile 2024: Valuation, Investors ...

AgeX Therapeutics General Information Description. AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting …See details»

AgeX Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Www.agexinc.com. Public Company | 2017 | California, United States | 100-250 | NYSE: AGE | www.agexinc.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»

Company AgeX Therapeutics, Inc. - MarketScreener.com

AgeX Therapeutics, Inc. 1101 Marina Village Parkway Suite 201. 94501, Alameda +510 671 8370. http://www.agexinc.comSee details»

AGEX - Overview, News & Similar companies | ZoomInfo.com

May 18, 2022 AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: …See details»

Agex Therapeutics Inc (AGE-A) Profile - The Globe and Mail

See the company profile for Agex Therapeutics Inc (AGE-A) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

AgeX’s Competitors, Revenue, Number of Employees, Funding

AgeX’s Profile, Revenue and Employees. AgeX is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of age-related degenerative …See details»

Company Information - RocketReach

AgeX Therapeutics, Inc. employs 12 employees. The AgeX Therapeutics, Inc. management team includes Andrea Park (Chief Financial Officer), Nafees Malik (Chief Operating Officer), and …See details»

AgeX Therapeutics, Inc. - Serina Therapeutics and AgeX …

Aug 30, 2023 About the Transaction, Management and Organization. Under the terms of the merger agreement, pending stockholder approval of the transaction, Serina will merge with a …See details»

Agex, Inc. Company Profile | San Antonio, TX - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for AGEX, INC. of San Antonio, TX. Get the latest business insights from Dun & Bradstreet.See details»

AgeX Therapeutics, Inc. - AgeX Therapeutics Reports Fourth …

Mar 29, 2022 ALAMEDA, Calif.--(BUSINESS WIRE)-- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and …See details»

AgeX Therapeutics (USA) Funding: $99.8M - Medical Startups

Dec 19, 2024 AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative...See details»

AgeX Therapeutics, Inc. Email Format | agexinc.com Emails

[email protected]: 100.0%. Email Verification Tool Instantly check any Microsoft email. Get free lookups per month. Verify Top AgeX Therapeutics, Inc. Employees Andrea Park Chief …See details»

AgeX Therapeutics, Inc. - AgeX Therapeutics Reports Fourth …

Mar 31, 2021 Sponsored research at The Ohio State University to Generate Proof-of-Concept Animal Data for AgeX’s Brown Adipose Tissue (BAT) Cell Therapy Candidate for Diabetes and …See details»

Minister Ng announces appointment of Alison Nankivell as new …

Dec 23, 2024 “I would like to express my sincere appreciation to Mairead Lavery for her exceptional leadership and dedication to EDC over the last 6 years and congratulate Alison …See details»

linkstock.net © 2022. All rights reserved